Mediterranean diet and health status: Active ingredients and pharmacological mechanisms
L Schwingshackl, J Morze… - British journal of …, 2020 - Wiley Online Library
The Mediterranean diet (MedDiet) is one of the most widely described and evaluated dietary
patterns in scientific literature. It is characterized by high intakes of vegetables, legumes …
patterns in scientific literature. It is characterized by high intakes of vegetables, legumes …
The butyrate story: old wine in new bottles?
W Scheppach, F Weiler - Current Opinion in Clinical Nutrition & …, 2004 - journals.lww.com
In the era of molecular biology our understanding of subcellular processes that ultimately
lead to inflammatory bowel disease or colorectal cancer has widened considerably. The …
lead to inflammatory bowel disease or colorectal cancer has widened considerably. The …
A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase
MC Myzak, PA Karplus, FL Chung, RH Dashwood - Cancer research, 2004 - AACR
Sulforaphane (SFN), a compound found at high levels in broccoli and broccoli sprouts, is a
potent inducer of phase 2 detoxification enzymes and inhibits tumorigenesis in animal …
potent inducer of phase 2 detoxification enzymes and inhibits tumorigenesis in animal …
[HTML][HTML] Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apcmin mice
MC Myzak, WM Dashwood, GA Orner… - The FASEB journal …, 2006 - ncbi.nlm.nih.gov
We recently reported that sulforaphane (SFN), an isothiocyanate from broccoli, inhibited
HDAC activity and increased the acetylation of histone H3 and histone H4 in human colon …
HDAC activity and increased the acetylation of histone H3 and histone H4 in human colon …
Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells
MC Myzak, K Hardin, R Wang, RH Dashwood… - …, 2006 - academic.oup.com
Sulforaphane (SFN), an isothiocyanate first isolated from broccoli, exhibits chemopreventive
properties in prostate cancer cells through mechanisms that are poorly understood. We …
properties in prostate cancer cells through mechanisms that are poorly understood. We …
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia
Preclinical studies with the histone deacetylase (HDAC) inhibitor depsipeptide (FK228) in
chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) have demonstrated …
chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) have demonstrated …
Mediterranean diet: prevention of colorectal cancer
MG Donovan, OI Selmin, TC Doetschman… - Frontiers in …, 2017 - frontiersin.org
Colorectal cancer (CRC) is the third most common cancer diagnosis and the second and
third leading cause of cancer mortality in men and women, respectively. However, the …
third leading cause of cancer mortality in men and women, respectively. However, the …
Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex
JM Blouin, G Penot, M Collinet, M Nacfer… - … journal of cancer, 2011 - Wiley Online Library
Butyrate, a short‐chain fatty acid produced by the colonic bacterial fermentation is able to
induce cell growth inhibition and differentiation in colon cancer cells at least partially through …
induce cell growth inhibition and differentiation in colon cancer cells at least partially through …
Histone deacetylase inhibitors up-regulate the expression of tight junction proteins
M Bordin, F D'Atri, L Guillemot, S Citi - Molecular Cancer Research, 2004 - AACR
Histone deacetylase (HDAC) inhibitors promote cell maturation, differentiation, and
apoptosis through changes in gene expression. Differentiated epithelial cells are …
apoptosis through changes in gene expression. Differentiated epithelial cells are …
Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter
H Nian, B Delage, JT Pinto, RH Dashwood - Carcinogenesis, 2008 - academic.oup.com
Histone deacetylase (HDAC) inhibitors have the potential to derepress epigenetically
silenced genes in cancer cells, leading to cell cycle arrest and apoptosis. In the present …
silenced genes in cancer cells, leading to cell cycle arrest and apoptosis. In the present …